Because MTA is a competitive inhibitor of methyltransferase enzymes, including histone and DNA methyltransferases (Williams-Ashman et al. 1982), it is possible that loss of MTAP may have effects on the epigenetic control of gene expression in tumor cells. Here, MTAP is linked to neoplasm.